Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cell-autonomous co-stimulatory function of membrane-bound CD100 promotes activation and differentiation of HBcAg-specific CD8<sup>+</sup> T cells.

Frontiers in immunology·2026

Same author

A generalizable system for antigenic peptide targeting across HLA-I allotypes.

bioRxiv : the preprint server for biology·2026

Same author

Artificial Intelligence-Powered Cystoscopy Diagnostic Support System: Clinical Application of Multiarchitecture Deep Learning Models.

Journal of endourology·2026

Same author

Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis.

Signal transduction and targeted therapy·2026

Same author

Synergistic Consortia with Bacillus megaterium A14 Enhance Cadmium Immobilization in the Arachis hypogaea Rhizosphere.

Current microbiology·2026

Same author

Global whole-genome, phylodynamic, and machine-learning analysis of <i>Glaesserella parasuis</i> serovars 2, 5, and 12.

Applied and environmental microbiology·2026

Same journal

Association between HPV-16 and HPV-18 viral loads and severity of cervical pre-invasive lesions in women with and without HIV in Botswana.

Frontiers in oncology·2026

Same journal

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study.

Frontiers in oncology·2026

Same journal

Case Report: Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma.

Frontiers in oncology·2026

Same journal

Analysis of ultrasonic characteristics in 12 cases of ovarian Sertoli-Leydig cell tumour.

Frontiers in oncology·2026

Same journal

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience.

Frontiers in oncology·2026

Same journal

Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an <i>in vitro</i> model of lung cancer.

Frontiers in oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Predictive model for PSA persistence after radical prostatectomy using machine learning algorithms.

Haotian Du¹, Guipeng Wang¹, Yongchao Yan¹

¹Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Frontiers in Oncology

|December 23, 2024

Summary

This summary is machine-generated.

A machine learning model using the Random Forest algorithm effectively predicts prostate-specific antigen (PSA) persistence after radical prostatectomy (RP). Key predictors include capsular invasion, positive surgical margin, preoperative PSA, and biopsy Gleason score, aiding clinical risk assessment and treatment planning.

Keywords:

PSA persistence machine learning prediction model radical prostatectomy random forest algorithm

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Related Experiment Videos

Last Updated: Jun 4, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Area of Science:

Urology
Oncology
Machine Learning in Medicine

Background:

Prostate-specific antigen (PSA) persistence after radical prostatectomy (RP) is a critical indicator of treatment outcome.
Accurate prediction of PSA persistence is essential for timely intervention and improved patient prognosis.

Purpose of the Study:

To evaluate the efficacy of machine learning algorithms in predicting PSA persistence post-RP.
To identify key risk factors associated with PSA persistence in patients undergoing RP.

Main Methods:

Retrospective analysis of 470 patients who underwent RP.
Inclusion of ten risk factors: age, BMI, preoperative PSA, biopsy Gleason score, PSAD, clinical tumor stage, lymph node status, seminal vesicle invasion, capsular invasion, and positive surgical margin.
Comparison of seven machine learning algorithms, with data split into training (70%) and testing (30%) sets.

Main Results:

The Random Forest model demonstrated superior performance, achieving an AUC of 0.8607 in the training set and 0.8011 in the test set.
Capsular invasion, positive surgical margin, preoperative PSA, and biopsy Gleason score were identified as the most significant predictors of PSA persistence.
142 (30.21%) patients in the cohort experienced PSA persistence.

Conclusions:

The Random Forest algorithm is a robust tool for developing a predictive model for PSA persistence after RP.
This study highlights significant risk factors, aiding clinicians in risk stratification and personalized treatment strategies for patients in the Asian region.
The findings support early intervention and improved management of patients at risk for PSA recurrence.